Abstract
BACKGROUND: The hyperglycemia in pregnancy (HIP) is classified as the gestational diabetes mellitus (GDM) and pre-gestational diabetes mellitus (PGDM). Metabolomic changes during pregnancy have been suggested to underlie the etiology of HIP, which influence fetal organogenesis and placental development. On one hand, the PGDM women suffer from hyperglycemic exposure in earlier gestation than GDM. On the other, type 2 diabetes mellitus (T2DM) is the most common type of PGDM. Therefore, it is of clinical implication to detect the metabolic alterations of T2DM pregnant women, especially for those with refractory and uncontrolled hyperglycemia. We aimed to figure out the metabolic profile of umbilical cord blood among pregnant women with T2DM and its influences on the fetal growth. METHODS: We included 48 uncontrolled T2DM singleton pregnancies and 52 matched healthy singleton pregnancies. Metabolites in umbilical cord blood were measured by liquid chromatography‒mass spectrometry analysis. RESULTS: We observed significant increases in the levels of several metabolites in umbilical cord blood samples from patients with uncontrolled T2DM, including alisol A, glycodeoxycholic acid, 3-quinolinecarboxylic acid- 7,8-dichloro-1,4-dihydro-4-oxo-, fraxetin, sphingosine, alpha-D-glucose, L-glutamine, isoalantolactone, L-leucine, and voriconazole. The abundance of alisol A was negatively correlated with the level of glucose in umbilical cord blood, and the abundance of L-leucine was positively correlated with the level of insulin in umbilical cord blood. The pathways of biosynthesis of amino acids and butanoate metabolism were enriched in the uncontrolled T2DM group. Further, the abundance of alisol A and L-leucine were positively correlated with the fetal weight in the uncontrolled T2DM group. CONCLUSION: The metabolic profile of umbilical cord blood among pregnant women with uncontrolled T2DM was different from that of the healthy pregnant women. The metabolic profile of umbilical cord blood from the uncontrolled T2DM women was characterized by the enrichment of the pathways of biosynthesis of amino acids and butanoate metabolism and the metabolites of alisol A and L-leucine.